[Association of polymorphism of 2'-5' oligoadenylate synthetase 1 gene with the susceptibility of hepatitis B virus infection and IFN-alpha treatment response].
Sun
Xiao-fei
XF
Department of Infectious Diseases, Affiliated Ruiji Hospital, Medical College, Shanghai Jiaotong University, Shanghai 200025, China.
Zhang
Xin-xin
XX
Yang
Zhi-tao
ZT
Xu
Jie
J
Huang
Ling
L
Gong
Qi-ming
QM
Jin
Gen-di
GD
Jiang
Jie-hong
JH
Gao
Jian
J
Lu
Min
M
Lu
Zhi-meng
ZM
D015088:2',5'-Oligoadenylate Synthetase / Q000235:genetics*; D000328:Adult; D002353:Carrier State / Q000821:virology*; D016022:Case-Control Studies; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy / Q000235:genetics* / Q000821:virology; D006515:Hepatitis B virus; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011110:Polymorphism, Genetic; D011994:Recombinant Proteins
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C475085:OAS1 protein, human; D015088:2',5'-Oligoadenylate Synthetase; C100416:peginterferon alfa-2a